Satraplatin (s) Increases Progression-free Survival (pfs) and Delays Pain Progression in Patients (pts) With Hormone Refractory Prostate Cancer (hrpc) That Have Progressed After Prior Docetaxel
Year: 2008
Type: conference-abstract
Source: European Urology Supplements
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2053143906
